ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway

Zhu, Mingwei; Niu, Jiamei; Jiang, Jian; Dong, Tianxiu; Chen, Yaodong; Yang, Xiuhua*; Liu, Pengfei*哈尔滨医科大学; 1
Life Sciences2022-3-15DOI: 10.1016/j.lfs.2022.120358
6被引3阅读
引用收藏
分享

摘要

Aims: Glioblastoma (GBM) is the most common and aggressive intracranial tumor with poor prognosis. A large majority of clinical chemotherapeutic agents cannot achieve the desired therapeutic effect. Chelerythrine (CHE), a natural component with multitudinous pharmacological functions, has been proven to have outstanding antitumor effects in addition to antibacterial, anti-inflammatory, and hypotensive effects. However, the antiGBM effect of CHE has not been reported to date. The purpose of this paper is to observe the anti-GBM effect of CHE and further explore the related mechanism. Materials and methods: GBM cell lines (U251 and T98G) and BALB/c nude mice were used in the experiments. Methyl thiazolyl tetrazolium (MTT) and clone formation assays were applied to detect the viability, proliferation and stemness of GBM cells. Flow cytometry was utilized to identify the effect of CHE on GBM apoptosis. Scratch and Transwell experiments reflected the migration and invasion of cells. In vivo, xenograft tumors were implanted subcutaneously in nude mice. The progression of tumors was assessed by ultrasound and magnetic resonance imaging. Finally, western blot, bioinformatics, and immunohistochemistry experiments were used to explore the molecular mechanisms in depth.Key findings: In vitro tests showed that CHE inhibited the proliferation, stemness, migration, and invasion of GBM cells and induced apoptosis. In vitro, CHE was observed to restrain the progression of xenograft tumors. We eventually proved that the cytotoxicity of CHE was relevant to the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway.Significance: CHE inhibited GBM progression by inhibiting the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway and is a potential chemotherapeutic drug for GBM.

学科与关键词

关键词
GlioblastomaChelerythrinesignaling pathwayTGFB1-ERK12Smad23-SnailZEB1
相关
加载中…
  • CCL2-targeted ginkgolic acid exerts anti-glioblastoma effects by inhibiting the JAK3-STAT1/PI3K-AKT signaling pathway
    Chen, Xi; Zhu, Mingwei; Zou, Xiaomeng; Mao, Yingxuan; Niu, Jiamei; Jiang, Jian; Dong, Tianxiu; Shi, Ying; Yang, Xiuhua*; Liu, Pengfei*Life Sciences, 2022, 311: 121174.被引 2
  • Valtrate, an iridoid compound in Valeriana, elicits anti-glioblastoma activity through inhibition of the PDGFRA/MEK/ERK signaling pathway
    Liu, Xuemeng; Hu, Yaotian; Xue, Zhiyi; Zhang, Xun; Liu, Xiaofei; Liu, Guowei; Wen, Muzi; Chen, Anjing; Huang, Bin; Li, Xingang; Yang, Ning*; Wang, Jian*Journal of Translational Medicine, 2023, 21(1): 147.被引 2
  • Therapeutic effect of natural polyphenols against glioblastoma
    Beylerli, Ozal; Beilerli, Aferin; Shumadalova, Alina; Wang, Xiaoxiong; Yang, Mingchun; Sun, Hanran; Teng, Lei*Frontiers in Cell and Developmental Biology, 2022, 10: 1036809.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Life Sciences
发表日期
2022-03-15
卷期
第 293 卷
页码
120358
DOI
10.1016/j.lfs.2022.120358
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81771894]

作者

  • Z

    Zhu, Mingwei (第一作者)

    1 · harbin med univ

  • N

    Niu, Jiamei

    1 · harbin med univ

查看全部 7 位作者收起作者
  • J

    Jiang, Jian

    1 · harbin med univ

  • D

    Dong, Tianxiu

    1 · harbin med univ

  • C

    Chen, Yaodong

    1 · harbin med univ

  • Y

    Yang, Xiuhua (通讯)

    1 · harbin med univ

  • L

    Liu, Pengfei (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417